CPIX
CUMBERLAND PHARMACEUTICALS INC
$5.60
-1.23%
$83.9M
No data for this timeframe.
Vol
Market Cap$83.9M
Cap SizeMicro Cap
Inst. Holders18 funds
Inst. Value$4.8M
Inst. Activity0 buys / 2 sells
Reddit Sentiment67° Warm
SEC Reports3
Recent Activity
May 26, 2026
SEC
Cumberland Pharmaceuticals is seeking shareholder approval to sell its FDA-approved commercial product portfolio (Acetad
DEFM14A — Impact 7/10
May 5, 2026
earnings_calendar
CPIX Q1 2026 Earnings Scheduled — 2026-05-05
Apr 23, 2026
SEC
Cumberland Pharmaceuticals is selling its commercial pharmaceutical products and related assets to Apotex for $100 milli
DEFA14A, 8-K — Impact 7/10
Mar 18, 2026
Insider
Herman James L was granted 2,500 shares
VP and Chief Compliance Office @ $2.80 ($7.0K)
Mar 18, 2026
Insider
Anthony Todd M. was granted 3,000 shares
Vice Pres Organizational Dev @ $2.80 ($8.4K)
Mar 18, 2026
Insider
Jones James was granted 1,800 shares
Director @ $2.80 ($5.0K)
Mar 9, 2026
SEC
Cumberland Pharmaceuticals Inc. (CPIX) filed a Definitive Additional Proxy Statement (DEFA14A) for its 2026 Annual Meeti
DEFA14A — Impact 3/10
Inst.
TWO SIGMA INVESTMENTS, LP — TRIM
24,485 shares ($97.5K)
Analyst Ratings
0Strong Buy
0Buy
3Hold
1Sell
2Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Dec 3, 2019 | B. Riley Securities | MAINTAIN | Buy |
| Nov 18, 2019 | B. Riley Securities | MAINTAIN | Buy |
| Aug 17, 2018 | B. Riley Securities | MAINTAIN | Buy → Buy |
| Apr 17, 2018 | B. Riley Securities | INITIATE | Buy |
| Apr 10, 2013 | UBS | MAINTAIN | Neutral |
Latest Reports
BULLISH
DEFM14A
7/10
Cumberland Pharmaceuticals is seeking shareholder approval to sell its FDA-approved commercial product portfolio (Acetad
May 26, 2026
BULLISH
DEFA14A, 8-K
7/10
Cumberland Pharmaceuticals is selling its commercial pharmaceutical products and related assets to Apotex for $100 milli
Apr 23, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| ROYAL BANK OF CANADA | — | — |
| RENAISSANCE TECHNOLOGIES LLC | $1.5M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.2M | — |
| DIMENSIONAL FUND ADVISORS LP | $898.2K | — |
| BlackRock, Inc. | $184.9K | TRIM |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 18, 2026 | Herman James | A | $7.0K |
| Mar 18, 2026 | Anthony Todd | A | $8.4K |
| Mar 18, 2026 | Jones James | A | $5.0K |
| Mar 18, 2026 | Young Caroline | A | $5.0K |
| Mar 18, 2026 | Krogulski Kenneth | A | $5.0K |
Reddit Sentiment
67°
Warm
Bearish
Neutral
Bullish
18 institutional holders with $4.8M total value (1,464,803 shares) as of 2026-Q1. Top holders: ROYAL, RENAISSANCE, VANGUARD.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | ROYAL BANK OF CANADA | 127 | $0.00 | 0.0% | — |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 470,696 | $1.5M | 32.1% | — |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 361,759 | $1.2M | 24.7% | — |
| 4 | DIMENSIONAL FUND ADVISORS LP | 276,359 | $898.2K | 18.9% | — |
| 5 | BlackRock, Inc. | 56,891 | $184.9K | 3.9% | TRIM -61.3% |
| 6 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 56,700 | $184.3K | 3.9% | — |
| 7 | VANGUARD FIDUCIARY TRUST CO | 45,623 | $148.3K | 3.1% | — |
| 8 | STATE STREET CORP | 39,510 | $128.4K | 2.7% | — |
| 9 | Marex Group plc | 36,423 | $118.4K | 2.5% | — |
| 10 | CITADEL ADVISORS LLC | 20,600 | $67.0K | 1.4% | TRIM -44.3% |
| 11 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 20,252 | $65.8K | 1.4% | — |
| 12 | Cresset Asset Management, LLC | 19,475 | $63.3K | 1.3% | — |
| 13 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 16,800 | $54.6K | 1.1% | — |
| 14 | CITADEL ADVISORS LLC | 16,643 | $54.1K | 1.1% | TRIM -44.3% |
| 15 | CITADEL ADVISORS LLC | 12,500 | $40.6K | 0.9% | TRIM -44.3% |
| 16 | TWO SIGMA INVESTMENTS, LP | 11,085 | $36.0K | 0.8% | TRIM -34.9% |
| 17 | MORGAN STANLEY | 3,260 | $10.6K | 0.2% | TRIM -70.9% |
| 18 | WELLS FARGO & COMPANY/MN | 100 | $325.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | TRIM | 37,591 | 24,485 | -34.9% | $97.5K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 17 | 9 | -47.1% | $36.00 | 2025-Q4 |
| CITADEL ADVISORS LLC | TRIM | 74,406 | 41,445 | -44.3% | $129.3K | 2025-Q3 |
| MORGAN STANLEY | TRIM | 12,398 | 3,605 | -70.9% | $11.2K | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 8,818 | 827 | -90.6% | $2.6K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | 94 | 17 | -81.9% | $53.00 | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | ADD | 22,755 | 32,265 | +41.8% | $108.1K | 2025-Q2 |
| UBS Group AG | ADD | 5,337 | 8,818 | +65.2% | $29.5K | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 37,649 | 22,755 | -39.6% | $96.3K | 2025-Q1 |
| UBS Group AG | TRIM | 8,195 | 5,337 | -34.9% | $22.6K | 2025-Q1 |
| BlackRock, Inc. | TRIM | 110,068 | 42,581 | -61.3% | $100.9K | 2024-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 139 | 65 | -53.2% | $154.00 | 2024-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 67 | 139 | +107.5% | $178.00 | 2024-Q3 |
10 unique insiders with 11 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 18, 2026 | Herman James L | VP and Chief Compliance Office | AWARD | 2,500 | $2.80 | $7.0K |
| Mar 18, 2026 | Anthony Todd M. | Vice Pres Organizational Dev | AWARD | 3,000 | $2.80 | $8.4K |
| Mar 18, 2026 | Jones James | Director | AWARD | 1,800 | $2.80 | $5.0K |
| Mar 18, 2026 | Young Caroline | Director | AWARD | 1,800 | $2.80 | $5.0K |
| Mar 18, 2026 | Krogulski Kenneth | Director | AWARD | 1,800 | $2.80 | $5.0K |
| Mar 18, 2026 | KAZIMI A J | Chairman and CEO | AWARD | 100,000 | $2.80 | $280.0K |
| Mar 18, 2026 | Hamm John M. | VP Chief Financial Officer | AWARD | 3,000 | $2.80 | $8.4K |
| Mar 18, 2026 | Bitterman Chris T. | Vice Pres Sales & Marketing | AWARD | 3,000 | $2.80 | $8.4K |
| Mar 18, 2026 | Brown Martin S JR | Director | AWARD | 1,800 | $2.80 | $5.0K |
| Mar 18, 2026 | Galante Joseph C | Director | AWARD | 1,800 | $2.80 | $5.0K |
| Mar 16, 2026 | KAZIMI A J | Chairman and CEO | TAX W/H | 5,845 | $3.06 | $17.9K |
3 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 5.7/10.
BULLISH
DEFM14A
7/10
Cumberland Pharmaceuticals is seeking shareholder approval to sell its FDA-approved commercial produ
May 26, 2026
BULLISH
DEFA14A, 8-K
7/10
Cumberland Pharmaceuticals is selling its commercial pharmaceutical products and related assets to A
Apr 23, 2026
NEUTRAL
DEFA14A
3/10
Cumberland Pharmaceuticals Inc. (CPIX) filed a Definitive Additional Proxy Statement (DEFA14A) for i
Mar 9, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Dec 2019): 0% buy across 6 analysts — 0 strong buy, 0 buy, 3 hold, 1 sell, 2 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2021-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2021-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
3 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 1 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Dec 3, 2019 | B. Riley Securities | MAINTAIN | — | Buy |
| Nov 18, 2019 | B. Riley Securities | MAINTAIN | — | Buy |
| Aug 17, 2018 | B. Riley Securities | MAINTAIN | Buy | Buy |
| Apr 17, 2018 | B. Riley Securities | INITIATE | — | Buy |
| Apr 10, 2013 | UBS | MAINTAIN | — | Neutral |
| Nov 12, 2012 | UBS | MAINTAIN | — | Neutral |
| Nov 9, 2012 | Wells Fargo | DOWNGRADE | Outperform | Market Perform |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| May 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Apr 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Mar 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Feb 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Jan 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
67°
Warm
Bearish
Neutral
Bullish
2 mentions
2 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Apr 23, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 23, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
May 5, 2026
earnings_calendar
CPIX Q1 2026 Earnings Scheduled — 2026-05-05
May 4, 2026
earnings_calendar
CPIX Q1 2026 Earnings Scheduled — 2026-05-04
Apr 23, 2026
short_volume
Short Volume: CPIX — 58.6% short (11.0M / 18.8M)
Short: 11,034,470 | Exempt: 118,161 | TRF Vol: 18,835,580 | Short Ratio: 58.6% | Off-exchange volume (dark pool + OTC)
Mar 3, 2026
earnings_calendar
CPIX Q4 2025 Earnings Scheduled — 2026-03-03